Last week, stock markets were rocked by a wave of sell recommendations. Many experts recommended selling stocks and investing in safer investments.
– On our own behalf –
Tip: Trade your stocks now for €0.00 at finanzen.net zero! Find out here
11th place: The ranking
Investors who want to buy or sell stocks often consult analyst opinions. In the last trading week, numerous experts again advised getting out of stocks. These shares were recommended for sale by the analysts.
Source: finanzen.net, image: SergeyP / Shutterstock.com
10th place: Zurich Insurance
The US bank JPMorgan has raised the price target for Zurich from 500 to 525 francs, but left the rating at “Underweight”. For analysis
Source: finanzen.net, Image: Jonathan Weiss / Shutterstock.com
9th place: Brenntag
DZ Bank has reduced the fair value for Brenntag from 45 to 41 euros and left the rating at “Sell”. For analysis
Source: finanzen.net, image: Brenntag AG
8th place: Swiss Re
The Canadian bank RBC has lowered the price target for Swiss Re from 125 to 118 francs and left the rating at “underperform”. For analysis
Source: finanzen.net, image: Swiss Re
7th place: GSK
The US bank JPMorgan has left GSK’s rating at “Underweight” with a price target of 1,700 pence, following detailed study data from Johnson & Johnson on Tecvayli plus Darzalex against multiple myeloma. For analysis
Source: finanzen.net, image: PD
6th place: thyssenkrupp
The British investment bank Barclays has left the rating for thyssenkrupp at “Underweight” based on figures and outlook with a price target of 7.30 euros. For analysis
Source: finanzen.net, image: thyssenkrupp AG
5th place: Unilever
The analysis firm Jefferies left Unilever’s rating at “underperform” with a price target of 4,000 pence after an investor event for the consumer goods group. For analysis
Source: finanzen.net, Image: OHN THYS/AFP/Getty Images
4th place: Roche
The analysis house Jefferies has left Roche’s rating at “underperform” with a price target of 230 francs. For analysis
Source: finanzen.net, image: Roche
3rd place: Carl Zeiss Meditec
The US bank JPMorgan has left the rating for Carl Zeiss Meditec at “Underweight” with a price target of 35.10 euros. For analysis
Source: finanzen.net, image: Carl Zeiss Meditec
2nd place: Zalando
The US analysis house Bernstein Research has left Zalando’s rating at “Underperform” with a price target of 23 euros. For analysis
Source: finanzen.net, Image: Hannelore Foerster/Getty Images
1st place: STMicroelectronics
The British investment bank Barclays has left the rating for STMicroelectronics at “Underweight” with a price target of 20 euros. For analysis
Source: finanzen.net, Image: Pavel Kapysh / Shutterstock.com